U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
SONTUZUMAB
INN  
INN  
Official Name English
EPITUMOMAB
WHO-DD  
Preferred Name English
AS-1402
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPISIALIN) (HUMAN-MOUSE MONOCLONAL HMFG-1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HMFG-1, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPISIALIN) (MOUSE MONOCLONAL HMFG-1 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL HMFG-1, DIMER
Common Name English
Epitumomab [WHO-DD]
Common Name English
sontuzumab [INN]
Common Name English
HUHMFG-1
Code English
Sontuzumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1512
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
NCI_THESAURUS C129823
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL2108341
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
PRIMARY
NCI_THESAURUS
C38697
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
PRIMARY
CAS
372075-37-1
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
PRIMARY
FDA UNII
3VD89OE565
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
PRIMARY
EVMPD
SUB01916MIG
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
PRIMARY
NCI_THESAURUS
C152108
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
ALTERNATIVE
INN
8438
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108403
Created by admin on Tue Apr 01 16:20:43 GMT 2025 , Edited by admin on Tue Apr 01 16:20:43 GMT 2025
PRIMARY
ACTIVE MOIETY
SONTUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966